ENTITY
3SBio Inc

3SBio Inc (1530 HK)

152
Analysis
Health Care • China
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
•28 Jun 2020 08:00

Last Week in Event SPACE: Jardine Matheson, Vedanta, Cromwell, Cardinal, Taubman, Mediawan

Last Week in Event SPACE ... Jardine Matheson Holdings (JM SP)'s buybacks accelerate, suggesting now is the time to reverse the set-up trade...

Logo
527 Views
Share
bearish•3SBio Inc
•02 Mar 2020 20:27

3SBio: The Frequent Board Turnover Is Just the Tip of the Iceberg of a Larger Governance Issue

3SBio, based in China develops, manufactures, markets and sells biopharmaceuticals. The company owns market-leading biopharmaceuticals franchises...

Share
bearish•3SBio Inc
•02 Mar 2020 17:10

3SBio: Valuation Trap with Tell-Tale Signs of Corporate Governance Issues

3SBio is a leading pharmaceutical company in China. It has a dominant market share in two of its key products. Recently, the company's share price...

Logo
416 Views
Share
bearish•Quantitative Analysis
•20 Jul 2019 11:52

Hong Kong Short Reporting - Insights from 12 July Data

We analyse the latest SFC data released last evening on short position reporting in Hong Kong for the week ended 12 July.Total short notional in...

Logo
535 Views
Share
•19 Jul 2019 11:28

SinoMab (中国抗体): Pipeline Concentrated on Autoimmune Therapy

SinoMab, the first Hong Kong-headquartered biotech company coming to list on the SEHK, plans to raise USD100 to 200 million.  In this insight, we...

Logo
900 Views
Share
x